Thalomid and Hypovolaemia - a phase IV clinical study of FDA data

Summary:

Hypovolaemia is reported as a side effect among people who take Thalomid (thalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Ambien, and have Bone loss.

The phase IV clinical study analyzes which people have Hypovolaemia when taking Thalomid. It is created by eHealthMe based on reports of 38,055 people who have side effects when taking Thalomid from the FDA, and is updated regularly.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.

What is Hypovolaemia?

Hypovolaemia (a decreased volume of circulating blood in the body) is found to be associated with 890 drugs and 838 conditions by eHealthMe. Check the latest studies of Hypovolaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

38,055 people reported to have side effects when taking Thalomid.
Among them, 29 people (0.08%) have Hypovolaemia.

Among these 29 people:

How long have people been on Thalomid when they have Hypovolaemia? *

What is the gender of people who have Hypovolaemia when taking Thalomid? *

female: 37.93 %
male: 62.07 %

What is the age of people who have Hypovolaemia when taking Thalomid? *

What are other drugs people take besides Thalomid? *

What are other side effects people have besides Hypovolaemia? *

Dehydration (dryness resulting from the removal of water): 21 people, 72.41%
Pleural Effusion (water on the lungs): 19 people, 65.52%
Acute Kidney Failure: 19 people, 65.52%
Fever: 18 people, 62.07%
High Blood Pressure: 17 people, 58.62%
Weakness: 16 people, 55.17%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 16 people, 55.17%
Enlarged Heart: 16 people, 55.17%
Thrombocytopenia (decrease of platelets in blood): 16 people, 55.17%
Nausea (feeling of having an urge to vomit): 16 people, 55.17%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 13 people, 44.83%
Bone Loss: 13 people, 44.83%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 6.90%
Sleep Disorder: 1 person, 3.45%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.45%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 3.45%
Post-Traumatic Stress Disorder: 1 person, 3.45%
Panic Disorder: 1 person, 3.45%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 3.45%
Hereditary Haemorrhagic Telangiectasia (hereditary -development of multiple abnormalities in the blood vessels): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Thalomid and have Hypovolaemia?

- Check whether Hypovolaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalomid:

Thalomid (38,099 reports)

Hypovolaemia treatments and more:

Hypovolaemia (8,125 reports)

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypovolaemia:

Hypovolaemia (890 drugs)

Browse all the conditions that are associated with Hypovolaemia:

Hypovolaemia (838 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalomid) and Thalomid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.